Current and experimental therapeutics for Fabry disease
Author:
Affiliation:
1. Department of Life, Health and Environmental Sciences University of L'Aquila L'Aquila Italy
2. Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology Temple University Philadelphia Pennsylvania USA
Publisher
Wiley
Subject
Genetics (clinical),Genetics
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/cge.13999
Reference81 articles.
1. Fabry disease
2. Fabry disease and its cardiac involvement
3. A Metabolomic Study Reveals Novel Plasma Lyso-Gb3 Analogs As Fabry Disease Biomarkers
4. Elevated globotriaosylsphingosine is a hallmark of Fabry disease
5. The effect of 12-month enzyme replacement therapy on myocardial perfusion in patients with Fabry disease
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fabry disease management: Current status, therapeutic challenges, and future horizons in drug delivery and artificial intelligence assisted diagnosis;Journal of Drug Delivery Science and Technology;2024-10
2. A systematic literature review on the health-related quality of life and economic burden of Fabry disease;Orphanet Journal of Rare Diseases;2024-04-30
3. Fabry‐specific treatment in Australia: time to align eligibility criteria with international best practices;Internal Medicine Journal;2024-01-11
4. The Role of α3β1 Integrin Modulation on Fabry Disease Podocyte Injury and Kidney Impairment;Toxins;2023-12-14
5. Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders;Advanced Drug Delivery Reviews;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3